Breaking News: (NASDAQ: XXII) 22nd Century Group, Inc.; Announces New Branded Products Order with Customer for SE Asia

New Alert: 22nd Century Group, Inc. (NASDAQ: XXII) Breaking News: 22nd Century Announces New Branded Products Order with Customer for Southeast Asia 10XProTrader Member, This is Kevin Vander with "10XProTrader", we have a brand new profile for you. It's, [22nd Century Group, Inc. (NASDAQ: XXII)]( We've never shied away from introducing companies that do things differently from their competitor herd. In fact, we embrace those innovators, especially when they present compelling investment opportunities. Today's profile this morning checks both those boxes. And in an industry with billions in revenue dollars up for grabs, this current $0.25 stock may be presenting a value proposition that's too attractive to ignore. And for smokers especially, with XXII telling them they don't need to quit smoking altogether, but instead take control of their nicotine intake and make healthier choices. [Click here for News Release]( [22nd Century Announces New Branded Products Order with Customer for Southeast Asia]( New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile Mocksville, North Carolina--(Newsfile Corp. - September 23, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced a new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. The first shipment is expected in the fourth quarter of 2024, with the opportunity to significantly expand volumes as the customer launches in key markets throughout 2025. "This new customer represents an exciting opportunity to deploy one of our underutilized in-house brand assets to drive new growth opportunities, expanding our presence in a market with a widespread smoking culture in Southeast Asia," said Larry Firestone, Chairman and CEO. "At scale, we believe this contract represents an opportunity to grow our manufacturing volumes by more than 30% over the next 15 months." "We have additional brands and assets that we can deploy into these or other markets in the U.S. and around the world," added Firestone. "We are currently discussing similar opportunities with customers interested in deploying those brands and predicates, as well as customers interested in offering a reduced nicotine content product under their own branding, helping us to build a new category around our innovative VLN® products." 22nd Century owns a number of brands which among others include Pinnacle, Moonlight, Magic and Ranger, in addition to its VLN® 95% reduced nicotine content branded cigarettes, the only combustible cigarette authorized by the U.S. Food and Drug Administration specifically designed to reduce smoking rates. The Company recently announced the launch of its VLN® branded products into the South Korean market, and expansion strategy in the U.S., which is expected to include flanker brands for additional reduced nicotine content products intended to help adult smokers to smoke less. About 22nd Century Group, Inc. 22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption. We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them smoke less. VLN® is the world's first and only combustible cigarette to receive a Modified Risk Tobacco Product designation from the FDA, which the FDA has mandated be described as a product that Helps You Smoke Less®. VLN® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether. Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN® products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion. Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets. Our mission is to sell the last cigarette before the 22nd Century. VLN® and Helps You Smoke Less® are registered trademarks of 22nd Century Limited LLC. Learn more at [xxiicentury.com]( on [X (formerly Twitter)]( on [LinkedIn]( and on [YouTube](. Learn more about VLN® at [tryvln.com](. Cautionary Note Regarding Forward-Looking Statements Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024, and in the Company's Quarterly Reports filed on May 15, 2024 and August 13, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law. ---------------------------- About 22nd Century Group, Inc. (NASDAQ: XXII) 22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using their breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, they have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and cigarettes containing 95% less nicotine. They received the first and only FDA MRTP authorization for a combustible cigarette in December 2021. The sole function of their cigarettes is to make it easier to reduce the number of cigarettes smoked. In tobacco, 22nd Century employs a unique and innovative platform of modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding, to deliver healthier solutions for pressing issues. They create new, proprietary plants with select alkaloid, terpenoid, and flavonoid profiles, improved yields, and valuable agronomic traits for the life science and consumer products industries. Learn more at [xxiicentury.com]( Rather than fight that trend, they've done something better by developing a product line that gives choices back to the consumer and, at the same time, pioneers a movement that is reshaping the tobacco industry. Now, XXII isn't saying that all of a sudden, nicotine is good. Far from it. But they are serving up a product option, its innovative VLN® (Very Low Nicotine) cigarettes, that can do more than appease those wanting nicotine- they're developing a whole new category that could also serve investor appetites craving innovative and revolutionary growth stock companies.  A game-changer in the reduced harm landscape... Its innovative VLN® cigarettes empower smokers to reduce nicotine consumption without sacrificing the smoking experience they know. That difference is a competitive advantage. And it's not just another nicotine delivery system; it's giving smokers the ability to make informed decisions about their nicotine intake. The value driver in its mission to create market and shareholder value is the FDA-approved VLN® cigarette, which contains 95% less nicotine than traditional cigarettes.  Here's the more important consideration from an investor perspective- XXII's VLN® cigarette is uniquely positioned as the only combustible cigarette authorized to be marketed as a Modified Risk Tobacco Product, carrying the powerful message that it "Helps You Smoke Less®." Learn more about VLN® at [tryvln.com](. 22nd Century Group, Inc. may be paving the way for a new standard in smoking that reflects progress, not replacement. If successful, this sub-dollar company could be behind a shift that could disrupt the entire tobacco landscape. That mission is in progress, evidenced by XXII's vision translating to real market traction. According to updates, sales of VLN® have exceeded expectations in many of the test markets established in 2023, leading XXII to expand its sales and marketing operations. Currently, VLN® is available in over 5,000 stores across 26 states, but that's just the beginning. [The first cigarette that helps you smoke less.]( VLN® is an FDA authorized, new-to-market product with 95% less nicotine than traditional cigarettes. This innovative product aids in reducing your smoking by considerably lowering your nicotine consumption. - First of Its Kind: The only tobacco cigarette authorized by the FDA to help you smoke less, VLN® offers an entirely new approach. - A Familiar Smoking Experience: VLN® cigarettes smoke, taste, and smell like what you're used to, just with less nicotine. VLN® and Helps You Smoke Less® are registered trademarks of 22nd Century Limited LLC. [tryvln.com](  All of the above contributes to an evidence-based case for why XXII needs to be considered for a growth stock portfolio. Remember, XXII's VLN® cigarettes don't deprive smokers of satisfaction. Instead, they allow smokers to enjoy a smoking routine with the added benefit of significantly reduced nicotine exposure. That delivers more than a win-win proposition—it also fills a gap in the harm-reduction nicotine market ripe for the taking. And that's exactly what XXII is in the process of doing. With its VLN® a trailblazer in the space, similar to early category creators in other industries that changed consumer behavior by meeting them where they are, not where companies wanted them to be. If you missed some of my recent big "10x Alerts"  I strongly suggest you get ready for our explosive new breakout alert... Because, you don't want to miss another winner with tremendous upside potential! Pay very close attention to your email inbox, your next alert is just around the corner. Yours for greater gains, Kevin Vander Publisher, 10XProTrader.com Investment Research Sources: [( [( [( [( [( [( [( [( [( [www.stocktitan.net/news/XXII/22nd-century-updates-strategic-growth-initiatives-for-h5vt2iq9hh35.html#:~:text=22nd%20Century%20Group%20plans%20to,their%2095%25%20less%20nicotine%20tobacco.]( [22nd Century Announces New Branded Products Order with Customer for Southeast Asia (yahoo.com)]( You are receiving this e-mail as part of your subscription to 10XProTrader. Please do not reply to this e-mail as this address is not monitored. Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET. © 2024 10XProTrader.com. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular inves∙tment situation. N∙o communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers, prior or during our reporting on the company. © 2024 10XProTrader.com, All Rights Reserved. 10XProTrader is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or inve∙stment for any specific individual. This communication is a paid a∙dvertisement. 10XProTrader.com and/or its subsidiaries and/or affiliates ("Company," "we," or "us") have been compensated $20,000 USD to disseminate this communication. Please note that we do not trade any securities that we profile. We do not hold positions in stocks we profile. We do not accept stock as a form of payment for our profiles. Please review the full disc∙laimer at [( for important information about this advertisement. © 2023 10XProTrader. All rights reserved., 340 Royal Poinciana Way Suite 317, 33480, Palm Beach, United States You may [unsubscribe]( or [change your contact details]( at any time.